Tutorial
These icons indicate there is something to be interacted with. Click it when you see it.
Tutorial
These icons indicate there is something to be interacted with. Click it when you see it.
Tutorial
These icons indicate there is something to be interacted with. Click it when you see it.
touchIN CONVERSATION
A relaxed discussion between two faculty focussed on real world clinical issues. Useful tips below will show how to navigate the activity. Join the conversation.
Close
Early diagnosis and treatment of NMOSD: Practical insights
Learning Objectives
After watching this activity, participants should be better able to:
- Identify the initial symptoms of NMOSD and its clinical characteristics at presentation
- Apply appropriate processes to ensure accurate and rapid diagnosis of NMOSD
- Choose appropriate management strategies based on patient symptoms and biomarker tests
Overview
In this activity, a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.
This activity is jointly provided by USF Health and touchIME. read more
Target Audience
Neurologists and ophthalmologists, including neuro-immunologists and neuro-ophthalmologists, involved in the management of NMOSD.
Disclosures
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
Faculty
Prof. John Chen Discloses: Consultancy fees from Horizon and UCB.
Prof. Friedemann Paul Discloses: Advisory board or panel fees from Alexion Pharma, Amgen, Biogen, Chugai Pharma, Förderpreis, Hexal, Horizon, Merck, Novartis, Novartis Pharma, Ridgeline Discovery, Roche, Sanofi, Teva GmbH and UCB. Consultancy fees from BioNTech, Bristol Myers Squibb, Hexal AG, Hoffmann-La Roche, MIAC AG, Roche Pharma and UCB Biopharma. Grants/research Support from Alexion, Amgen, Hexal (relationship terminated), Horizon, Novartis, Roche, Sanofi (relationship terminated) and UCB.
Content Reviewer
Danielle Walker, DNP, APRN, AGNP-C has no financial interests/relationships or affiliations in relation to this activity.
Touch Medical Contributor
Adriano Boasso has no financial interests/relationships or affiliations in relation to this activity.
USF Health Office of Continuing Professional Development and touchIME staff have no financial interests/relationships or affiliations in relation to this activity.
Requirements for Successful Completion
In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.
If you have questions regarding credit please contact cpdsupport@usf.edu.
Accreditations
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and touchIME. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The European Union of Medical Specialists (UEMS) – European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).
Advanced Practice Providers
Physician Assistants may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
The AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM by ACCME-accredited providers. APRNs who participate will receive a certificate of completion commensurate with the extent of their participation.
Date of original release: 25 July 2024. Date credits expire: 25 July 2025.
If you have any questions regarding credit please contact cpdsupport@usf.edu.
To obtain the CE/CME credit(s) from this activity, please complete this post-activity test.
Claim CreditYou may also be interested in...
REGISTER NOW FOR FREE ACCESS TO
- 1000+ topical and insightful peer-reviewed journal articles
- 100+ hours of bite-sized congress highlights
- 10 major therapy areas packed with the latest scientific advances
- 150+ specialties offering learn-on-the-go medical education
- + Concise email updates and newsletters so you never miss out